|
1
|
Sauer R, Becker H, Hohenberger W, Rödel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
et al: Preoperative versus postoperative chemoradiotherapy for
rectal cancer. N Engl J Med. 351:1731–1740. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH,
Park W, Choi DH, Nam H, Kim JS, Cho MJ, et al: Pathologic complete
response of primary tumor following preoperative chemoradiotherapy
for locally advanced rectal cancer: Long-term outcomes and
prognostic significance of pathologic nodal status (KROG 09-01).
Ann Surg. 252:998–1004. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim NK, Baik SH, Seong JS, Kim H, Roh JK,
Lee KY, Sohn SK and Cho CH: Oncologic outcomes after neoadjuvant
chemoradiation followed by curative resection with tumor-specific
mesorectal excision for fixed locally advanced rectal cancer:
Impact of postirradiated pathologic downstaging on local recurrence
and survival. Ann Surg. 244:1024–1030. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zorcolo L, Rosman AS, Restivo A, Pisano M,
Nigri GR, Fancellu A and Melis M: Complete pathologic response
after combined modality treatment for rectal cancer and long-term
survival: A meta-analysis. Ann Surg Oncol. 19:2822–2832. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim NK and Hur H: New Perspectives on
predictive biomarkers of tumor response and their clinical
application in preoperative chemoradiation therapy for rectal
cancer. Yonsei Med J. 56:1461–1477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ryan JE, Warrier SK, Lynch AC, Ramsay RG,
Phillips WA and Heriot AG: Predicting pathological complete
response to neoadjuvant chemoradiotherapy in locally advanced
rectal cancer: A systematic review. Colorectal Dis. 18:234–246.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stijns RCH, Tromp MR, Hugen N and de Wilt
JHW: Advances in organ preserving strategies in rectal cancer
patients. Eur J Surg Oncol. 44:209–219. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Li L, Yang L, Yuan J, Lv B, Yao Y
and Xing S: Wait-and-see treatment strategies for rectal cancer
patients with clinical complete response after neoadjuvant
chemoradiotherapy: A systematic review and meta-analysis.
Oncotarget. 7:44857–44870. 2016.PubMed/NCBI
|
|
9
|
Chang GJ, Rodriguez-Bigas MA, Eng C and
Skibber JM: Lymph node status after neoadjuvant radiotherapy for
rectal cancer is a biologic predictor of outcome. Cancer.
115:5432–5440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duchalais E, Glyn Mullaney T, Spears GM,
Kelley SR, Mathis K, Harmsen WS and Larson DW: Prognostic value of
pathological node status after neoadjuvant radiotherapy for rectal
cancer. Br J Surg. 105:1501–1509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Swellengrebel HA, Bosch SL, Cats A,
Vincent AD, Dewit LG, Verwaal VJ, Nagtegaal ID and Marijnen CA:
Tumour regression grading after chemoradiotherapy for locally
advanced rectal cancer: A near pathologic complete response does
not translate into good clinical outcome. Radiother Oncol.
112:44–51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jwa E, Kim JH, Han S, Park JH, Lim SB, Kim
JC, Hong YS, Kim TW and Yu CS: Nomogram to predict ypN status after
chemoradiation in patients with locally advanced rectal cancer. Br
J Cancer. 111:249–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Newton AD, Li J, Jeganathan AN, Mahmoud
NN, Epstein AJ and Paulson EC: A nomogram to predict lymph node
positivity following neoadjuvant chemoradiation in locally advanced
rectal cancer. Dis Colon Rectum. 59:710–717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
von den Grün JM, Hartmann A, Fietkau R,
Ghadimi M, Liersch T, Hohenberger W, Weitz J, Sauer R, Wittekind C,
Ströbel P, et al: Can clinicopathological parameters predict for
lymph node metastases in ypT0-2 rectal carcinoma? Results of the
CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials. Radiother Oncol.
128:557–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pomerri F, Pucciarelli S, Maretto I,
Zandoná M, Del Bianco P, Amadio L, Rugge M, Nitti D and Muzzio PC:
Prospective assessment of imaging after preoperative
chemoradiotherapy for rectal cancer. Surgery. 149:56–64. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ryu KH, Kim SH, Yoon JH, Lee Y, Paik JH,
Lim YJ and Lee KH: Diffusion-weighted imaging for evaluating lymph
node eradication after neoadjuvant chemoradiation therapy in
locally advanced rectal cancer. Acta Radiol. 57:133–141. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Antoni D, Burckel H, Josset E and Noel G:
Three-dimensional cell culture: A breakthrough in vivo. Int J Mol
Sci. 16:5517–5527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta N, Liu JR, Patel B, Solomon DE,
Vaidya B and Gupta V: Microfluidics-based 3D cell culture models:
Utility in novel drug discovery and delivery research. Bioeng
Transl Med. 1:63–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park MC, Jeong H, Son SH, Kim Y, Han D,
Goughnour PC, Kang T, Kwon NH, Moon HE, Paek SH, et al: Novel
morphologic and genetic analysis of cancer cells in a 3D
microenvironment identifies STAT3 as a regulator of tumor
permeability barrier function. Cancer Res. 76:1044–1054. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zschenker O, Streichert T, Hehlgans S and
Cordes N: Genome-wide gene expression analysis in cancer cells
reveals 3D growth to affect ECM and processes associated with cell
adhesion but not DNA repair. PLoS One. 7:e342792012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Storch K, Eke I, Borgmann K, Krause M,
Richter C, Becker K, Schröck E and Cordes N: Three-dimensional cell
growth confers radioresistance by chromatin density modification.
Cancer Res. 70:3925–3934. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC cancer staging manual. 8th. Springer; New
York: 2017, View Article : Google Scholar
|
|
23
|
Kang JH, Kim YC, Kim H, Kim YW, Hur H, Kim
JS, Min BS, Kim H, Lim JS, Seong J, et al: Tumor volume changes
assessed by three-dimensional magnetic resonance volumetry in
rectal cancer patients after preoperative chemoradiation: The
impact of the volume reduction ratio on the prediction of
pathologic complete response. Int J Radiat Oncol Biol Phys.
76:1018–1025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han YD, Kim WR, Park SW, Cho MS, Hur H,
Min BS, Baik SH, Lee KY and Kim NK: Predictors of pathologic
complete response in rectal cancer patients undergoing total
mesorectal excision after preoperative chemoradiation. Medicine
(Baltimore). 94:e19712015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim H, Myoung S, Koom WS, Kim NK, Kim MJ,
Ahn JB, Hur H and Lim JS: MRI risk stratification for tumor relapse
in rectal cancer achieving pathological complete remission after
neoadjuvant chemoradiation therapy and curative resection. PLoS
One. 11:e01462352016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
An C, Huh H, Han KH, Kim MJ, Kim NK, Kim H
and Lim JS: Use of preoperative MRI to select candidates for local
excision of MRI-Staged T1 and T2 rectal cancer: Can MRI select
patients with N0 tumors? Dis Colon Rectum. 58:923–930. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mandard AM, Dalibard F, Mandard JC, Marnay
J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G,
et al: Pathologic assessment of tumor regression after preoperative
chemoradiotherapy of esophageal carcinoma. Clinicopathologic
correlations. Cancer. 73:2680–2686. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garcia-Aguilar J, Renfro LA, Chow OS, Shi
Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet
JE, et al: Organ preservation for clinical T2N0 distal rectal
cancer using neoadjuvant chemoradiotherapy and local excision
(ACOSOG Z6041): Results of an open-label, single-arm,
multi-institutional, phase 2 trial. Lancet Oncol. 16:1537–1546.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Renehan AG, Malcomson L, Emsley R, Gollins
S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP,
et al: Watch-and-wait approach versus surgical resection after
chemoradiotherapy for patients with rectal cancer (the OnCoRe
project): A propensity-score matched cohort analysis. Lancet Oncol.
17:174–183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
De Nardi P and Carvello M: How reliable is
current imaging in restaging rectal cancer after neoadjuvant
therapy? World J Gastroenterol. 19:5964–5972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim DW, Kim DY, Kim TH, Jung KH, Chang HJ,
Sohn DK, Lim SB, Choi HS, Jeong SY and Park JG: Is T classification
still correlated with lymph node status after preoperative
chemoradiotherapy for rectal cancer? Cancer. 106:1694–1700. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Read TE, Andujar JE, Caushaj PF, Johnston
DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG and
Kodner IJ: Neoadjuvant therapy for rectal cancer: Histologic
response of the primary tumor predicts nodal status. Dis Colon
Rectum. 47:825–831. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi JP, Kim SJ, Park IJ, Hong SM, Lee JL,
Yoon YS, Kim CW, Lim SB, Lee JB, Yu CS and Kim JC: Is the
pathological regression level of metastatic lymph nodes associated
with oncologic outcomes following preoperative chemoradiotherapy in
rectal cancer? Oncotarget. 8:10375–10384. 2017.PubMed/NCBI
|
|
34
|
Loos M, Quentmeier P, Schuster T, Nitsche
U, Gertler R, Keerl A, Kocher T, Friess H and Rosenberg R: Effect
of preoperative radio(chemo)therapy on long-term functional outcome
in rectal cancer patients: A systematic review and meta-analysis.
Ann Surg Oncol. 20:1816–1828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schrag D, Weiser MR, Goodman KA, Gonen M,
Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem
JG, et al: Neoadjuvant chemotherapy without routine use of
radiation therapy for patients with locally advanced rectal cancer:
A pilot trial. J Clin Oncol. 32:513–518. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Min BS, Kim NK, Pyo JY, Kim H, Seong J,
Keum KC, Sohn SK and Cho CH: Clinical impact of tumor regression
grade after preoperative chemoradiation for locally advanced rectal
cancer: Subset analyses in lymph node negative patients. J Korean
Soc Coloproctol. 27:31–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
